Page last updated: 2024-08-16

temozolomide and gsk1210151a

temozolomide has been researched along with gsk1210151a in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Jiang, X; Yang, H; Yang, S; Yao, Z; Zhao, H	1

Other Studies

1 other study(ies) available for temozolomide and gsk1210151a

Article	Year
BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction. Cancer gene therapy, 2020, Volume: 27, Issue:3-4 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Brain Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Female; Gene Knockout Techniques; Glioblastoma; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Proto-Oncogene Proteins; Temozolomide; Transcription Factors; Xenograft Model Antitumor Assays	2020

Article

Year

BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction.

Cancer gene therapy, 2020, Volume: 27, Issue:3-4

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Brain Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Female; Gene Knockout Techniques; Glioblastoma; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Proto-Oncogene Proteins; Temozolomide; Transcription Factors; Xenograft Model Antitumor Assays

2020